Mediating effects of inflammatory biomarkers on insulin resistance associated with obesity. (Q51507603)

6 April 2018

title

Mediating effects of inflammatory biomarkers on insulin resistance associated with obesity. (English)

1 reference

6 April 2018

0 references

0 references

1 reference

1 reference

1 reference

2

Frank B Hu

1 reference

6 April 2018

5

James B Meigs

1 reference

6 April 2018

4

Nader Rifai

1 reference

6 April 2018

JoAnn E. Manson

series ordinal

3

object named as

JoAnn E Manson

1 reference

6 April 2018

author name string

Deborah J Wexler

series ordinal

1

1 reference

6 April 2018

publication date

1 October 2005

1 reference

6 April 2018

published in

Obesity

1 reference

6 April 2018

volume

13

1 reference

6 April 2018

page(s)

1772-1783

1 reference

6 April 2018

issue

10

1 reference

6 April 2018

Insulin resistance and hypersecretion in obesity. European Group for the Study of Insulin Resistance (EGIR).

cites work

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2005.216

Waist circumference as the best predictor of noninsulin dependent diabetes mellitus (NIDDM) compared to body mass index, waist/hip ratio and other anthropometric measurements in Mexican Americans--a 7-year prospective study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2005.216

Insulin sensitivity, insulin secretion, and abdominal fat: the Insulin Resistance Atherosclerosis Study (IRAS) Family Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2005.216

Visceral fat and race-dependent health risks in obese nondiabetic premenopausal women.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2005.216

Subcutaneous abdominal fat and thigh muscle composition predict insulin sensitivity independently of visceral fat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2005.216

Total body fat content and fat topography are associated differently with in vivo glucose metabolism in nonobese and obese nondiabetic women

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2005.216

The metabolically obese, normal-weight individual revisited.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2005.216

Metabolic and body composition factors in subgroups of obesity: what do we know?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2005.216

C-reactive protein, interleukin 6, and risk of developing type 2 diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2005.216

Chronic subclinical inflammation as part of the insulin resistance syndrome: the Insulin Resistance Atherosclerosis Study (IRAS).

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2005.216

Elevated levels of acute-phase proteins and plasminogen activator inhibitor-1 predict the development of type 2 diabetes: the insulin resistance atherosclerosis study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2005.216

Inflammatory markers and risk of developing type 2 diabetes in women.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2005.216

Biomarkers of endothelial dysfunction and risk of type 2 diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2005.216

Is it possible to derive a reliable estimate of human visceral and subcutaneous abdominal adipose tissue from simple anthropometric measurements?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2005.216

Report of the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2005.216

Physical activity and incidence of non-insulin-dependent diabetes mellitus in women.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2005.216

Diet, lifestyle, and the risk of type 2 diabetes mellitus in women

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2005.216

Walking compared with vigorous physical activity and risk of type 2 diabetes in women: a prospective study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2005.216

Homeostasis model assessment: insulin resistance and ?-cell function from fasting plasma glucose and insulin concentrations in man

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2005.216

The relation of markers of inflammation to the development of glucose disorders in the elderly: the Cardiovascular Health Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2005.216

Adipose expression of tumor necrosis factor-alpha: direct role in obesity-linked insulin resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2005.216

Cellular adhesion molecules and atherogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2005.216

Abdominal fat and insulin resistance in normal and overweight women: Direct measurements reveal a strong relationship in subjects at both low and high risk of NIDDM.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2005.216

Obesity is associated with macrophage accumulation in adipose tissue

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2005.216

C-reactive protein in healthy subjects: associations with obesity, insulin resistance, and endothelial dysfunction: a potential role for cytokines originating from adipose tissue?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2005.216

Oxidative stress and stress-activated signaling pathways: a unifying hypothesis of type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2005.216

Uncoupling of obesity from insulin resistance through a targeted mutation in aP2, the adipocyte fatty acid binding protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2005.216

Protection from obesity-induced insulin resistance in mice lacking TNF-alpha function

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2005.216

Tumor necrosis factor alpha is a key component in the obesity-linked elevation of plasminogen activator inhibitor 1

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2005.216

Insulin stimulates interleukin-6 and tumor necrosis factor-alpha gene expression in human subcutaneous adipose tissue

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2005.216

Elevated circulating free fatty acid levels impair endothelium-dependent vasodilation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2005.216

Endothelial dysfunction: cause of the insulin resistance syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2005.216

Blood flow and muscle metabolism: a focus on insulin action.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2005.216

Direct evidence for insulin-induced capillary recruitment in skin of healthy subjects during physiological hyperinsulinemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2005.216

Adiponectin and development of type 2 diabetes in the Pima Indian population

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2005.216

Modulation of insulin activities by leptin

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2005.216

Expression of the functional leptin receptor mRNA in pancreatic islets and direct inhibitory action of leptin on insulin secretion

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2005.216

The hormone resistin links obesity to diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2005.216

Cellular mechanisms of insulin resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2005.216

Banting lecture 2001: dysregulation of fatty acid metabolism in the etiology of type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2005.216

Effect of weight loss and lifestyle changes on vascular inflammatory markers in obese women: a randomized trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2005.216

Adiposity as Compared with Physical Activity in Predicting Mortality among Women

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2005.216

Diabetes incidence in Pima indians: contributions of obesity and parental diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2005.216

Weight as a risk factor for clinical diabetes in women.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2005.216

Body fat distribution and risk of non-insulin-dependent diabetes mellitus in women. The Nurses' Health Study

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2005.216

Waist circumference and not body mass index explains obesity-related health risk

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2005.216

Visceral adipose tissue impairs insulin secretion and insulin sensitivity but not energy expenditure in obesity

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2005.216

Relationship of generalized and regional adiposity to insulin sensitivity in men with NIDDM

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2005.216

Subdivisions of subcutaneous abdominal adipose tissue and insulin resistance

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2005.216

Cigarette smoking, relative weight, and menopause.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2005.216

Validity of self-reported waist and hip circumferences in men and women

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2005.216

How good a marker is insulin level for insulin resistance?

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2005.216

Exploration of simple insulin sensitivity measures derived from frequently sampled intravenous glucose tolerance (FSIGT) tests. The Insulin Resistance Atherosclerosis Study.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2005.216

Adipose tissue is a major source of interleukin-1 receptor antagonist: upregulation in obesity and inflammation

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2005.216

Adipose tissue as an endocrine and paracrine organ

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2005.216

The relation of body fat mass and distribution to markers of chronic inflammation

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2005.216

C-reactive protein is independently associated with total body fat, central fat, and insulin resistance in adult women

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2005.216

Role of tissue-specific blood flow and tissue recruitment in insulin-mediated glucose uptake of human skeletal muscle

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2005.216

Waist circumference and obesity-associated risk factors among whites in the third National Health and Nutrition Examination Survey: clinical action thresholds.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2005.216

31 March 2020

Identifiers

DOI

10.1038/OBY.2005.216

1 reference

6 April 2018

PubMed ID

16286525

1 reference

6 April 2018